11 April 2018 | News
Audit of its active pharmaceutical ingredient (API) Cuernavaca plant in Mexico by the USFDA was completed with zero observations
Reddy's Laboratories has received establishment inspection report (EIR) from the US health regulator for its Cuernavaca facility in Mexico.
The company had earlier said in a regulatory filing that audit of its active pharmaceutical ingredient (API) Cuernavaca plant in Mexico by the United States Food and Drug Administration (USFDA) was completed with zero observations.
As per the USFDA, after the completion of an inspection of a facility, an EIR is issued to a company detailing inspectional findings.